Big Move For NovaBay Pharmaceuticals, Inc.
Fri, Dec 30, 2022 at 07:06 PM
NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT) soared at $1.95, a gain of 40.3%. On Fri, Dec 30, 2022, NBY:NYSEMKT touched a New 2-Week High of $1.95. From Fri, Dec 16, 2022, the stock recorded 44.44% Up Days and 60.00% Green Days
About NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT)
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing & developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX & CELLERX.
Top 10 Gainers:
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 104.5%
- 180 Life Sciences Corp. (ATNF:NASDAQ), 79.37%
- SoundHound AI Inc. (SOUN:NASDAQ), 71.84%
- Palisade Bio Inc. (PALI:NASDAQ), 61.49%
- F-star Therapeutics Inc. (FSTX:NASDAQ), 54.52%
- Kala Pharmaceuticals, Inc. (KALA:NASDAQ), 53.58%
- United Insurance Holdings Corp. (UIHC:NASDAQ), 47.22%
- EZGO Technologies Ltd. (EZGO:NASDAQ), 43.38%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 40.29%
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 39.26%